Drug & medication recalls Moderate risk

Lidocaine HCl/Epinephrine recalled over sterility concerns

Recall date
December 6, 2021
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Edge Pharma, LLC recalls Lidocaine HCl/Epinephrine, Sterile Buffered Solution for Injection (PF) 1% / 1:100,000, 3 mL per syringe, Edge Pharma,…
Recall number
D-0396-2022
FDA classification
Class II
Brand / firm
Edge Pharma, LLC
Sold / distributed
nationwide

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Lidocaine HCl/Epinephrine, Sterile Buffered Solution for Injection (PF) 1% / 1:100,000, 3 mL per syringe, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, (802) 992-1178, NDC 05446-1268-01

Get recall alerts

Free email alert whenever Edge Pharma, LLC has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Edge Pharma, LLC